OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
464
Results
Show all
Save search
Copy query
Show results for
Unknown
(399)
Transcriptomics
(23)
Genomics
(23)
Proteomics
(11)
Metabolomics
(5)
Clinical
(2)
Other
(1)
Organisms
Homo sapiens
(13)
Mus musculus
(12)
Schizophyllum commune H4-8
(9)
Mycobacterium tuberculosis SP7
(9)
Oryza sativa Japonica Group
(9)
Crotalus durissus terrificus
(9)
Eriocheir sinensis
(9)
Candidatus Endoriftia persephonae
(9)
Mycobacterium tuberculosis SP10
(9)
Mycobacterium tuberculosis SP13
(9)
Cotesia typhae
(9)
Mycobacterium tuberculosis SP22
(9)
Cepaea nemoralis
(9)
Enterobacter ludwigii
(9)
Corynebacterium diphtheriae bv. mitis str. ISS 3319
(9)
Olea europaea
(9)
Chlamydomonas reinhardtii
(9)
Lama
(9)
Planorbella pilsbryi
(9)
Wolbachia sp. wMelPop
(9)
Pyricularia oryzae P131
(9)
Enterococcus mundtii CRL35
(9)
Pongo pygmaeus
(9)
Oncorhynchus tshawytscha
(9)
Pseudomonas canadensis
(9)
Strongylocentrotus purpuratus
(9)
Craterostigma plantagineum
(9)
Influenza A virus (A/California/04/2009(H1N1))
(9)
Salmonella enterica subsp. enterica serovar Typhimurium
(9)
Rattus norvegicus
(2)
Organisms
Mus musculus
(13)
Homo sapiens
(4)
Rattus norvegicus
(1)
Repository
ENA
(21)
biostudies-arrayexpress
(14)
geo
(12)
pride
(9)
MetaboLights
(5)
jPOST
(1)
MassIVE
(1)
Tissue
Cell culture
(2)
B-lymphoblast cell line
(1)
Mast cell
(1)
Keratinocyte
(1)
Lymph node
(1)
Blood plasma
(1)
Primary cell
(1)
Hepatocyte
(1)
B cell
(1)
Liver
(1)
Neutrophil
(1)
Disease
Colorectal Neoplasms
(2)
Disease free
(2)
Vitamin B12 deficiency
(1)
Technology Type
Mass Spectrometry
(9)
Shotgun proteomics
(4)
Mass spectrometry
(3)
Mass spectrometry assay
(2)
Bottom-up proteomics
(2)
Affinity purification coupled with mass spectrometry proteomics
(2)
Immunopeptidomics
(1)
All-ion fragmentation
(1)
Gel-based experiment
(1)
Instrument Platform
Liquid Chromatography MS - positive - reverse phase
(2)
Liquid Chromatography MS - negative - reverse phase
(2)
Orbitrap Ascend
(1)
Liquid Chromatography MS - negative - reversed-phase-chromatography
(1)
Liquid Chromatography MS - alternating - reverse-phase
(1)
Liquid Chromatography MS - positive - reverse-phase
(1)
Liquid Chromatography MS - negative - reverse-phase
(1)
Liquid Chromatography MS - negative - hilic
(1)
Liquid Chromatography MS - positive - hilic
(1)
Publication Date
2025
(7)
2013
(5)
2012
(4)
2026
(3)
2015
(2)
2014
(2)
2007
(2)
2024
(2)
2020
(2)
2016
(2)
2022
(2)
2021
(2)
2019
(2)
2017
(1)
2011
(1)
2008
(1)
2018
(1)
2023
(1)
Metabolite Name
Hapten
(5)
Hexadecanedioic acid
(5)
Uridine
(5)
Pantothenic acid
(4)
Azelaic acid
(4)
Cytidine
(4)
Inosine
(4)
Edta citrate
(3)
Perfluorovaleric acid
(3)
Pseudomonine
(3)
Ethyl glucuronide
(3)
N-Acetylaspartic acid
(3)
Ergocornine
(3)
Prednisone
(3)
6-Hydroxymelatonin
(3)
Paxilline
(3)
Phosphoribosyl formamidocarboxamide
(3)
Prostaglandin A2
(3)
Xanthurenic acid
(3)
Indolelactic acid
(3)
Sweroside
(3)
Fumaric acid
(3)
Taurine
(3)
Xanthosine
(3)
Citric acid
(3)
Sebacic acid
(3)
Glyceric acid
(3)
Porphobilinogen
(3)
Pantetheine
(3)
Dodecanedioic acid
(3)
First Public Date
2024
(5)
2014
(5)
2025
(2)
2020
(2)
2016
(2)
2021
(1)
2019
(1)
2018
(1)
2015
(1)
2013
(1)
Modification
4-dinitrophenyl modified residue
(1)
Study status
Withdrawn
(1)
Completed
(1)
Study type
Transcription profiling by array
(8)
Methylation profiling by array
(4)
Interventional
(2)
RNA-seq of coding RNA
(1)
RNA-seq of non coding RNA
(1)
Release Date
2019
(34)
2022
(33)
2023
(30)
2020
(29)
2017
(25)
2021
(25)
2025
(23)
2014
(23)
2018
(23)
2015
(21)
2013
(21)
2024
(21)
2012
(20)
2016
(20)
2009
(11)
2011
(8)
2008
(8)
2007
(7)
2010
(5)
2000
(5)
2005
(4)
2003
(4)
2026
(3)
2006
(3)
2004
(2)
1999
(2)
2002
(1)
2001
(1)
1998
(1)
Lab affiliation
Stockholm University
(2)
MRC Centre for Drug Safety Science, Dept Molecular and Clinical Pharmacology, University of Liverpool
(1)
Laboratory of Immunology, Division of Biotechnology Review and Research III, Office of Biotechnology Products,Center for Drugs Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
(1)
State Key Laboratory of NBC Protection for Civilian
(1)
Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen
(1)
Max Planck Institute of Immunobiology and Epigenetics Proteomics Unit Stuebeweg 51 79108 Freiburg, Germany
(1)
Centre for Proteomic Research B85, Life Sciences Building University of Southampton University Road Highfield Southampton, Hants. SO17 1BJ United Kingdom
(1)
Northwestern University, Department of Chemistry
(1)
Location
Netherlands
(1)
United States
(1)
Tags
xref:PubMed:39550253
(2)
xref:PubMed:23028731
(2)
xref:PubMed:29991564
(1)
xref:PubMed:40595611
(1)
xref:PubMed:39164311
(1)
xref:PubMed:39700316
(1)
xref:PubMed:27596266
(1)
xref:PubMed:42548722
(1)
xref:PubMed:39213029
(1)
xref:PubMed:24751728
(1)
xref:PubMed:26236467
(1)
xref:PubMed:27924814
(1)
xref:PubMed:26205579
(1)
xref:PubMed:22561152
(1)
xref:PubMed:40168127
(1)
xref:PubMed:23728175
(1)
xref:PubMed:18958736
(1)
Keyword
TF2 (Recombinant, humanized Tri-Fab bsMAb composed of 2 humanized MN-14 anti-CEA Fab x and one 679 anti-HSG Fab)
(1)
IMP288 (DOTA-di-HSG hapten-peptide for 111In/90Y labeling)
(1)
Radioimmunotherapy
(1)
Pretargeting
(1)
Lutetium 177
(1)
Phase I clinical trial
(1)
Antibodies, Bispecific
(1)
Bispecific antibody
(1)
Antibodies
(1)
Immunoglobulins
(1)
Previous
page
1 / 47
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
47
Next
page
Sort
by:
Relevance
Page size
10
Structural Analysis of Anti-Hapten Antibodies to Identify Long-Range Structural Movements Induced by Hapten Binding.
Not available
S-EPMC8044860
|
biostudies-literature
Cite
Modulating cocaine vaccine potency through hapten fluorination.
Not available
S-EPMC3637684
|
biostudies-literature
Cite
Alternative Hapten Design for Zearalenone Immunoreagent Generation.
Not available
S-EPMC8953469
|
biostudies-literature
Cite
Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
Not available
S-EPMC4472500
|
biostudies-literature
Cite
Probing the effects of hapten stability on cocaine vaccine immunogenicity.
Not available
S-EPMC3946501
|
biostudies-literature
Cite
hapten-specific BCR repertoires of New Zealand White Rabbit
PRJNA825090
|
ENA
Cite
Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse.
Not available
S-EPMC3983143
|
biostudies-literature
Cite
Methamphetamine Vaccines: Improvement through Hapten Design.
Not available
S-EPMC5895457
|
biostudies-literature
Cite
scRNA-seq analysis of dendritic cells in skin draining lymph nodes of CLEC4C-DTR mice treated with FITC hapten
scRNA-seq analysis of dendritic cells in skin draining lymph nodes of CLEC4C-DTR mice treated with FITC hapten
PRJNA678882
|
ENA
Cite
Effects of hapten density on the induced antibody repertoire.
Not available
S-EPMC3462448
|
biostudies-literature
Cite
Previous
page
1 / 47
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
47
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
